KCC009 (C007B-363329)

KCC009, a transglutaminase 2 (TG2) inhibitor, induces p53-independent radiosensitization.In VitroThe inhibition rates were 15.33±1.46 (%) for H1299/WT-p53 cells, and 14.31±1.90 (%) for H1299/M175H-p53 cells when cells were treated with KCC009 at concentration of 3.91 uM. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:Solid. Specification: 0.98 Molecular Formula: C21H22BrN3O5 Molecular Weight: 476.32 PubChem CID: 644312 Isomeric SMILES: C1C(ON=C1Br)CNC(=O)[C@H](CC2=CC=C(C=C2)O)NC(=O)OCC3=CC=CC=C3

UPC:

12142207

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

K647145-25mg

CAS:

744198-19-4

Product Size:

25mg